5 minute read
FDA's Abrupt Resolution of Tirzepatide Shortage Creates Uncertainty for Patients and Pharmacists
FDA's sudden removal of tirzepatide from the drug shortage list has left patients and pharmacists scrambling. Compounding pharmacies can no longer produce the medication, creating challenges for patient care.